CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamakage, M.
Right arrow Articles by Namiki, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamakage, M.
Right arrow Articles by Namiki, A.
Canadian Journal of Anesthesia 48:435-438 (2001)
© Canadian Anesthesiologists' Society, 2001

General Anesthesia

Production of compound A under low-flow anesthesia is affected by type of anesthetic machine

Michiaki Yamakage, MD PhD, Akira Kimura, MD, Xiangdong Chen, MD, Naoki Tsujiguchi, MD, Yasuhiro Kamada, MD and Akiyoshi Namiki, MD PhD

From the Department of Anesthesiology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.

Address correspondence to: Dr. Michiaki Yamakage, Department of Anesthesiology, Sapporo Medical University School of Medicine, South 1, West 16, Chuo-ku, Sapporo, Hokkaido, 060-8543, Japan. Phone: 81-11-611-2111 (ext. 3568); Fax: 81-11-631-9683; E-mail: yamakage{at}sapmed.ac.jp

Purpose: The purpose was to compare the concentrations of compound A in inspired gas breathed by patients produced by different types of anesthetic machines under prolonged sevoflurane low-flow anesthesia.

Methods: The anesthetic machines tested were ExcelTM 210 SE (Datex-Ohmeda, Louisville, CO), CiceroTM (Dräger, Lübeck, Germany), and AS/3TM ADU (Datex-Ohmeda, Louisville, CO). Anesthesia expected to last more than four hours was maintained with 2.0% sevoflurane and nitrous oxide (0.5 L•min–1) / oxygen (0.5 L•min–1). The concentrations of compound A, obtained from the inspiratory limb of the circle system, were measured using a gas chromatograph.

Results: When ExcelTM and CiceroTM were used, concentrations of compound A increased steadily from the baseline values to 28 and 29 (mean) ppm, respectively, at two hours after exposure to sevoflurane and became constant. There was no significant difference between the concentrations of compound A produced by these anesthetic machines. In contrast, the new anesthetic machine AS/3TM was associated with lower concentrations of compound A (6 ppm at one hour, P <0.05 compared with ExcelTM and CiceroTM), and the concentration did not change significantly thereafter.

Conclusion: In spite of the use of a conventional carbon dioxide (CO2) absorbent with strong bases, the anesthetic machine AS/3TM with a small volume of canister/soda lime (900 ml/700 ml) produced lower concentrations of compound A than those produced by the other machines.




This article has been cited by other articles:


Home page
Anesth. Analg.Home page
M.-P. L. A. Bouche, L. F. M. Versichelen, M. M. R. F. Struys, J. F. P. Van Bocxlaer, A. P. De Leenheer, E. P. Mortier, and G. Rolly
No Compound A Formation with Superia(R) During Minimal-Flow Sevoflurane Anesthesia: A Comparison with Sofnolime(R)
Anesth. Analg., December 1, 2002; 95(6): 1680 - 1685.
[Abstract] [Full Text] [PDF]


Home page
Canadian J. AnesthesiaHome page
E. I Eger II
Compound A: does it matter?/Le compose A : est-ce important?
Can J Anesth, May 1, 2001; 48(5): 427 - 430.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Canadian Anesthesiologists' Society.